Search research articles
Contact Us
Filters
Showing results (41-50 of 175) with videos related to
Page
of 18
Sort By:
Contraception
|
December 3, 2011
Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial
David F Archer, Frank Z Stanczyk, Arkady Rubin, et al.
Menopause (New York, N.Y.)
|
March 7, 2018
Vaginal pH: a simple assessment highly correlated with vaginal morphology and symptoms in postmenopausal women
Kelly M Tucker, Keshav Godha, Sebastian Mirkin, et al.
Contraception
|
January 18, 2015
A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women
Anh Dinh, Intira Sriprasert, Alistair R Williams, et al.
International Journal of Molecular Sciences
|
July 27, 2024
Validation of an In Vitro Diagnostic Test for Endometriosis: Impact of Confounding Medical Conditions and Lesion Location
Elza Daoud, David F Archer, Fabio Parazzini, et al.
Contraception
|
August 6, 2023
The efficacy, safety, and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users
Mitchell D Creinin, Alicyoy Angulo, Enrico Colli, et al.
Contraception
|
December 12, 2012
Therapeutically equivalent pharmacokinetic profile across three application sites for AG200-15, a novel low-estrogen dose contraceptive patch
Frank Z Stanczyk, David F Archer, Arkady Rubin, et al.
Contraception
|
August 25, 2009
Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimen
David F Archer, George Kovalevsky, Susan A Ballagh, et al.
Menopause (New York, N.Y.)
|
August 22, 2013
A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women
David F Archer, Thomas Schmelter, Matthias Schaefers, et al.
Menopause (New York, N.Y.)
|
June 23, 2017
Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause
Fernand Labrie, David F Archer, Céline Martel, et al.
American Journal of Obstetrics and Gynecology
|
September 16, 2014
Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women
Andrew M Kaunitz, David F Archer, Daniel R Mishell, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 175) with videos related to
Sort By:
Page
of 18
Contraception
|
December 3, 2011
Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial
David F Archer, Frank Z Stanczyk, Arkady Rubin, et al.
Menopause (New York, N.Y.)
|
March 7, 2018
Vaginal pH: a simple assessment highly correlated with vaginal morphology and symptoms in postmenopausal women
Kelly M Tucker, Keshav Godha, Sebastian Mirkin, et al.
Contraception
|
January 18, 2015
A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women
Anh Dinh, Intira Sriprasert, Alistair R Williams, et al.
International Journal of Molecular Sciences
|
July 27, 2024
Validation of an In Vitro Diagnostic Test for Endometriosis: Impact of Confounding Medical Conditions and Lesion Location
Elza Daoud, David F Archer, Fabio Parazzini, et al.
Contraception
|
August 6, 2023
The efficacy, safety, and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users
Mitchell D Creinin, Alicyoy Angulo, Enrico Colli, et al.
Contraception
|
December 12, 2012
Therapeutically equivalent pharmacokinetic profile across three application sites for AG200-15, a novel low-estrogen dose contraceptive patch
Frank Z Stanczyk, David F Archer, Arkady Rubin, et al.
Contraception
|
August 25, 2009
Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimen
David F Archer, George Kovalevsky, Susan A Ballagh, et al.
Menopause (New York, N.Y.)
|
August 22, 2013
A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women
David F Archer, Thomas Schmelter, Matthias Schaefers, et al.
Menopause (New York, N.Y.)
|
June 23, 2017
Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause
Fernand Labrie, David F Archer, Céline Martel, et al.
American Journal of Obstetrics and Gynecology
|
September 16, 2014
Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women
Andrew M Kaunitz, David F Archer, Daniel R Mishell, et al.
Page
of 18